The efficacy of bevacizumab in addition to platinum-based chemotherapy for first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer (NSCLC): Final results of AVALANCHE, an observational cohort study.

Edina Tolnay,Veronika Sárosi,Erzsébet Juhász,Zsuzsanna Sztancsik,György Losonczy,Gyula Ostoros,Laszlo Mandoky

The efficacy of bevacizumab in addition to platinum-based chemotherapy for first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer (NSCLC): Final results of AVALANCHE, an observational cohort study.

2014

Edina Tolnay
Veronika Sárosi
Erzsébet Juhász
Zsuzsanna Sztancsik
György Losonczy
Gyula Ostoros
Laszlo Mandoky

e19123 Background: Results of two phase III, and two phase IV trials have shown that first-line bevacizumab (BEV) in combination with chemotherapy improves clinical outcomes in patients with advanc...

Keywords:

non-small cell lung cancer (NSCLC)
Bevacizumab
Pathology
Cohort study
Cancer research
Chemotherapy
Medicine
Oncology
Internal medicine
first line treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations